Drug Profile
Research progarmme: bacterial infection vaccines - Protein Potential
Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Protein Potential
- Class Bacterial vaccines; Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Plague; Tularaemia
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for preclinical development in Plague(Prevention) in USA (Parenteral)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Tularaemia(Prevention) in USA (Parenteral)
- 19 Jul 2016 Preclinical trials in Plague (Prevention) in USA (Parenteral)